Show simple item record

FieldValueLanguage
dc.contributor.authorMuscat, Danielle M
dc.contributor.authorMorris, Georgina M
dc.contributor.authorBell, Katy J.L.
dc.contributor.authorCvejic, Erin
dc.contributor.authorSmith, Jenna
dc.contributor.authorJansen, Jesse
dc.contributor.authorThomas, Rae
dc.contributor.authorBonner, Carissa
dc.contributor.authorDoust, Jenny
dc.contributor.authorMcCaffery, Kirsten
dc.date.accessioned2021-04-26T02:31:07Z
dc.date.available2021-04-26T02:31:07Z
dc.date.issued2021en
dc.identifier.urihttps://hdl.handle.net/2123/24979
dc.description.abstractRecent US guidelines lowered the threshold for diagnosing hypertension while other international guidelines use alternative/no labels for the same group (blood pressure [BP], <140/90 mm Hg). We investigated potential benefits and harms of hypertension and high-normal BP labels, compared with control, among people at lower risk of cardiovascular diseaseen
dc.language.isoenen
dc.publisherLippincott, Williams & Wilkinsen
dc.relation.ispartofCirculation: Cardiovascular Quality and Outcomesen
dc.rightsCopyright All Rights Reserveden
dc.subjectguidelinesen
dc.subjecthypertensionen
dc.subjectclinical trialen
dc.subjectoutcome assessmenten
dc.subjectevidence based medicineen
dc.titleBenefits and Harms of Hypertension and High-Normal Labels: A Randomized Experimenten
dc.typeArticleen
dc.subject.asrc1117 Public Health and Health Servicesen
dc.identifier.doi10.1161/CIRCOUTCOMES.120.007160
dc.relation.arc1104136
dc.relation.nhmrc1174523
dc.relation.nhmrc1162149
dc.relation.nhmrc1122788
dc.relation.nhmrc1121110
usyd.facultySeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Healthen
usyd.citation.volume14en
usyd.citation.issue4en
workflow.metadata.onlyYesen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.